Ravi S Lankalapalli

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 16

Top Venues

Organic letters

The Journal of antibiotics

Exploration of targeted anti-tumor therapy

ACS organic & inorganic Au

National Institute for Interdisciplinary Science and Technology CSIR

The Graduate Center, City University of New York (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Institute for Interdisciplinary Science and Technology CSIR Dec 22 2011

India

Scientist :: Chemical Sciences and Technology Division

Education History

The Graduate Center, City University of New York Aug 29 2003 - May 29 2009

United States

PHD :: Chemistry

Publications

Balan Abhijith, Natakkakath Kaliyathan Raveena, Reshma Mullan Velandy, Ravi S Lankalapalli
Artifacts from the methanolic extract of Solanum nigrum Linn. Natural product research (2023)
Faisal M Athikkavil, Sreekumar U Aiswarya, Remya Johny, Meghna Sudhesh, Amrutha A Nisthul, Ravi S Lankalapalli, Ruby John Anto, Smitha V Bava
A potent bioactive fraction against colon cancer from Plectranthus vettiveroides . Exploration of targeted anti-tumor therapy 4 (2) (2023)
Faisal M Athikkavil, Sreekumar U Aiswarya, Remya Johny, Meghna Sudhesh, Amrutha A Nisthul, Ravi S Lankalapalli, Ruby John Anto, Smitha V Bava
A potent bioactive fraction against colon cancer from Plectranthus vettiveroides . Exploration of targeted anti-tumor therapy 4 (2) (2023)
D K Induja, A R S Jesmina, Manu M Joseph, Shanmughan Shamjith, Nagaraja Ingaladal, Kaustabh Kumar Maiti, B S Dileep Kumar, Ravi S Lankalapalli
Isolation of two new stereochemical variants of streptophenazine by cocultivation of Streptomyces NIIST-D31, Streptomyces NIIST-D47, and Streptomyces NIIST-D63 strains in 3 C 2 combinations. The Journal of antibiotics (2023)
Maniyamma Aswathy, Mohammed Sadik N K, Purushothaman C Harikrishnan, Sasikumar Parameswaran, Kokkuvayil Vasu Radhakrishnan, Ravi S Lankalapalli
α/β-Stereo- and diastereoselective glycosylation with n -pentenyl glycoside donors, promoted by N -iodosuccinimide and catalyzed by chiral Brønsted acid. Organic & biomolecular chemistry (2023)
Faisal M Athikkavil, Sreekumar U Aiswarya, Remya Johny, Meghna Sudhesh, Amrutha A Nisthul, Ravi S Lankalapalli, Ruby John Anto, Smitha V Bava
A potent bioactive fraction against colon cancer from Plectranthus vettiveroides . Exploration of targeted anti-tumor therapy 4 (2) (2023)
Abdul Rasheed Safiya Jesmina, D K Induja, Thankappan Drissya, Chakiniplackal Rajan Sruthi, Kozhiparambil Gopalan Raghu, Shijulal Nelson-Sathi, Bhaskaran Nair Saraswathy Amma Dileep Kumar, Ravi S Lankalapalli
In vitro antibacterial effects of combination of ciprofloxacin with compounds isolated from Streptomyces luteireticuli NIIST-D75. The Journal of antibiotics (2023)
Thankappan Drissya, D K Induja, M S Poornima, A R S Jesmina, Bernard Prabha, Mathew Saumini, Cherumuttathu H Suresh, K G Raghu, B S Dileep Kumar, Ravi S Lankalapalli
A novel aureothin diepoxide derivative from Streptomyces sp. NIIST-D31 strain. The Journal of antibiotics 75 (9) (2022)
Mundanattu Swetha, Chenicheri K Keerthana, Tennyson P Rayginia, Lekshmi R Nath, Nair Hariprasad Haritha, Anwar Shabna, Kalishwaralal Kalimuthu, Arun K Thangarasu, Sreekumar U Aiswarya, Somaraj Jannet, Sreekumar Pillai, Kuzhuvelil B Harikumar, Sankar Sundaram, Nikhil Ponnoor Anto, Dee H Wu, Ravi S Lankalapalli, Rheal Towner, Noah Isakov, Sathyaseelan S Deepa, Ruby John Anto
Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Mohanan Biji, Kokkuvayil Vasu Radhakrishnan, Ravi S Lankalapalli
Tandem Photoisomerization and Transannular Cyclizations of Zerumbone Epoxide: A Model for Diversity-Oriented Synthesis Using Abundant Natural Products. Organic letters 23 (15) (2021)
Jaice Ravindran, Velickakathu O Yadhukrishnan, Reghuvaran S Asha, Ravi S Lankalapalli
Dienaminodioate based multicomponent reactions with post-benzylic oxidative transformations mediated by DDQ. Organic & biomolecular chemistry 18 (20) (2021)
Arun K Thangarasu, Velickakathu O Yadhukrishnan, K A Krishnakumar, Sanjay Suresh Varma, Ravi S Lankalapalli
Cu(I)-azidopyrrolo[3,2- d ]pyrimidine Catalyzed Glaser-Hay Reaction under Mild Conditions. ACS organic & inorganic Au 2 (1) (2021)
Arun K Thangarasu, Velickakathu O Yadhukrishnan, K A Krishnakumar, Sanjay Suresh Varma, Ravi S Lankalapalli
Cu(I)-azidopyrrolo[3,2- d ]pyrimidine Catalyzed Glaser-Hay Reaction under Mild Conditions. ACS organic & inorganic Au 2 (1) (2021)
Kollery S Veena, Greeshma Gopalan, Murali Madhukrishnan, Sunil Varughese, Kokkuvayil Vasu Radhakrishnan, Ravi S Lankalapalli
Putative Biomimetic Route to 8-Oxabicyclo[3.2.1]octane Motif from a Humulene Sesquiterpenoid Zerumbone. Organic letters 22 (16) (2020)
Vellekkatt Jamsheena, Chikkagundagal K Mahesha, M Nibin Joy, Ravi S Lankalapalli
Metal-Free Diaryl Etherification of Tertiary Amines by Ortho-C(sp2)-H Functionalization for Synthesis of Dibenzoxazepines and -ones. Organic letters 19 (24) (2017)
Chandrasekhar Challa, Sunil Varughese, Cherumuttathu H Suresh, Ravi S Lankalapalli
Metal-Free Multiple Carbon-Carbon and Carbon-Hydrogen Bond Activations via Charge-Switching Mechanism in Unstrained Diindolylmethanes. Organic letters 19 (16) (2017)

Ravi S Lankalapalli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ravi S Lankalapalli